Vascular Grafts Market 2024-2028: Size and Risks and complications associated with vascular grafting; growth driven by the Product, Some of key Companies Positioned Strategically

The vascular grafts market size by Product (Endovascular grafts, Bypass grafts, Hemodialysis grafts, and Peripheral grafts) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 1518.4 million. The market is expected to grow at a CAGR of   7.08% between 2024 and 2028.

• In the business context, vascular grafts complications significantly impact long-term patient outcomes, contributing to both mortality and morbidity rates. Infections in vascular grafts, including infected grafts, pseudoaneurysms, and aortoenteric fistulas, pose a significant risk, even though they are relatively uncommon. Untreated vascular graft infections can lead to severe consequences, such as graft thrombosis, hemorrhage, and overwhelming sepsis ischemia. The majority of these infections arise during the initial surgery. Regarding Endovascular Aneurysm Repair (EVAR), its less invasive nature introduces unique complications. The most common types of endoleaks observed are Type I (attachment site/seal failure, up to 10%), Type II (through a collateral vessel, 40%), and Type III (graft failure/tear, 4%). Despite the advancements in technology and surgical techniques, it is crucial to remain vigilant and proactive in addressing these complications to ensure optimal patient outcomes.
• The vascular grafts market represents a significant business opportunity due to the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive surgical procedures. Vascular grafts are essential medical devices used to replace damaged or diseased blood vessels, and their market is expected to grow steadily due to advancements in biomaterials and surgical techniques. Companies in this sector focus on research and development to produce innovative and effective grafts, ensuring patient safety and optimal clinical outcomes.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Abbott Laboratories
• Artivion Inc.
• Aruga Technologies
• B.Braun SE
• Becton Dickinson and Co.
• Bentley InnoMed GmbH
• BIOTRONIK SE and Co. KG
• BIOVIC Sdn Bhd
• Cardinal Health Inc.
• Cook Group Inc.
• Endologix LLC
• Getinge AB
• Heart Medical Europe BV
• InnAVasc Medical Inc.
• Japan Lifeline Co. Ltd.
• LeMaitre Vascular Inc.
• Lombard Medical Ltd.
• Medtronic Plc
• MicroPort Scientific Corp.
• Terumo Corp.
• Vascular Graft Solutions Ltd.
• W. L. Gore and Associates Inc.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/